Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, CEO and Director

Chief Operating Officer

CFO and Chief Corp. Deve. Off.

Chief Commercial Officer

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-21	Premium	acquired	Premium	Premium	Premium	-
2023-10-10	Premium	acquired	Premium	Premium	Premium	President, CEO and Director
2023-10-10	Premium	acquired	Premium	Premium	Premium	-
2023-09-14	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-09-14	Premium	sold	Premium	Premium	Premium	-
2023-08-21	Premium	sold	Premium	Premium	Premium	-
2023-08-21	Premium	sold	Premium	Premium	Premium	-
2023-08-21	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-08-18	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-08-18	Premium	sold	Premium	Premium	Premium	-
2023-08-18	Premium	sold	Premium	Premium	Premium	-
2023-08-17	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-08-17	Premium	sold	Premium	Premium	Premium	-
2023-08-17	Premium	sold	Premium	Premium	Premium	-
2023-06-15	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-06-15	Premium	sold	Premium	Premium	Premium	-
2023-06-15	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	sold	Premium	Premium	Premium	-
2023-06-13	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-05-25	Premium	sold	Premium	Premium	Premium	-
2023-05-25	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2023-05-25	Premium	sold	Premium	Premium	Premium	President, CEO and Director
2023-05-25	Premium	sold	Premium	Premium	Premium	-
2023-05-25	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer

HUMA - Humacyte, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for HUMA